• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌患者的生存和预后因素。

Survival and prognostic factors in patients with oral squamous cell carcinoma.

机构信息

Department of Pathology Avenida Professor Moraes Rego, 1235 CEP 50670-901, Recife, Pernambuco, Brazil

出版信息

Med Oral Patol Oral Cir Bucal. 2021 May 1;26(3):e387-e392. doi: 10.4317/medoral.24242.

DOI:10.4317/medoral.24242
PMID:33037796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8141315/
Abstract

BACKGROUND

This study aimed to evaluate sociodemographic and clinical factors influencing overall survival (OS) in patients with oral squamous cell carcinoma (OSCC).

MATERIAL AND METHODS

Medical charts of 547 patients with OSCC from a public hospital in northeastern Brazil seen between 1999 and 2013 were evaluated. Survival analysis was performed using the Kaplan-Meier method. The influence of age, sex, ethnicity, clinical stage, anatomical location, type of treatment, and comorbidities on the patients' prognosis was evaluated. Cox proportional hazards regression model was used to identify independent prognostic factors.

RESULTS

The 5-year OS was 39%. Multivariate analysis showed that age < 40 years (HR = 2.20; 95%CI: 1.02-4.72) and a single treatment modality (HR = 1.91; 95%CI: 1.37-2.67) were associated with a poor prognosis, while early clinical stage resulted in better outcomes (HR = 0.38; 95%CI: 0.25-0.58).

CONCLUSIONS

OSCC patients in advanced clinical stages, diagnosed at a younger age, and submitted to a single therapeutic modality have a poorer prognosis.

摘要

背景

本研究旨在评估影响口腔鳞状细胞癌(OSCC)患者总生存率(OS)的社会人口学和临床因素。

材料与方法

对 1999 年至 2013 年期间在巴西东北部一家公立医院就诊的 547 例 OSCC 患者的病历进行评估。采用 Kaplan-Meier 方法进行生存分析。评估年龄、性别、种族、临床分期、解剖部位、治疗方式和合并症对患者预后的影响。使用 Cox 比例风险回归模型确定独立的预后因素。

结果

5 年 OS 率为 39%。多因素分析显示,年龄<40 岁(HR=2.20;95%CI:1.02-4.72)和单一治疗方式(HR=1.91;95%CI:1.37-2.67)与预后不良相关,而早期临床分期则导致更好的结果(HR=0.38;95%CI:0.25-0.58)。

结论

临床分期较晚、诊断时年龄较小、接受单一治疗方式的 OSCC 患者预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e4/8141315/0fb1369f5891/medoral-26-e387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e4/8141315/0fb1369f5891/medoral-26-e387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7e4/8141315/0fb1369f5891/medoral-26-e387-g001.jpg

相似文献

1
Survival and prognostic factors in patients with oral squamous cell carcinoma.口腔鳞状细胞癌患者的生存和预后因素。
Med Oral Patol Oral Cir Bucal. 2021 May 1;26(3):e387-e392. doi: 10.4317/medoral.24242.
2
Epidemiological, clinical, and prognostic analysis of oral squamous cell carcinoma diagnosed and treated in a single hospital in Galicia (Spain): a retrospective study with 5-year follow-up.在加利西亚(西班牙)的一家医院诊断和治疗的口腔鳞状细胞癌的流行病学、临床和预后分析:一项具有 5 年随访的回顾性研究。
Med Oral Patol Oral Cir Bucal. 2024 Jan 1;29(1):e36-e43. doi: 10.4317/medoral.26047.
3
Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.肿瘤浸润免疫细胞在临床早期口腔鳞状细胞癌中的预后价值
J Oral Pathol Med. 2023 May;52(5):372-380. doi: 10.1111/jop.13357. Epub 2022 Oct 5.
4
[A novel prognostic index for oral cancer in Fujian province].[福建省口腔癌的一种新型预后指数]
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Jun 10;39(6):841-846. doi: 10.3760/cma.j.issn.0254-6450.2018.06.028.
5
Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.口腔鳞状细胞癌患者的肌肉减少症和肌肉减少性肥胖评估:一项回顾性单中心研究。
J Craniomaxillofac Surg. 2023 Jan;51(1):7-15. doi: 10.1016/j.jcms.2023.01.014. Epub 2023 Jan 30.
6
Prognostic Abilities of Pre- and Post-Treatment Inflammatory Markers in Oral Squamous Cell Carcinoma: Stepwise Modelling.治疗前后炎症标志物对口腔鳞状细胞癌预后能力的预测:逐步建模。
Medicina (Kaunas). 2022 Oct 10;58(10):1426. doi: 10.3390/medicina58101426.
7
Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.晚期口腔鳞状细胞癌的超深度靶向测序鉴定出一种基于突变的预后基因特征。
Oncotarget. 2015 Jul 20;6(20):18066-80. doi: 10.18632/oncotarget.3768.
8
Novel Prediction Models for Patients With Oral Squamous Cell Carcinoma at Different Anatomical Sites.不同解剖部位口腔鳞状细胞癌患者的新型预测模型。
J Oral Maxillofac Surg. 2021 Nov;79(11):2358-2369. doi: 10.1016/j.joms.2021.06.023. Epub 2021 Jun 22.
9
Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of as an Independent and Favorable Predictor of Overall Survival.苏丹口腔鳞状细胞癌患者唾液宏基因组分析确定口腔定植更高水平的 是总生存的独立和有利预测因子。
Front Cell Infect Microbiol. 2021 Oct 12;11:673465. doi: 10.3389/fcimb.2021.673465. eCollection 2021.
10
Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.含锌指 AN1 结构域蛋白 4 是预测口腔鳞状细胞癌转移和预后不良的新型标志物。
J Clin Pathol. 2018 May;71(5):436-441. doi: 10.1136/jclinpath-2017-204770. Epub 2017 Oct 26.

引用本文的文献

1
Immunohistochemical Markers in the Early Identification of Oral Squamous Cell Carcinoma: A Systematic Review.免疫组织化学标志物在口腔鳞状细胞癌早期诊断中的应用:一项系统综述
Clin Cosmet Investig Dent. 2025 Aug 12;17:363-373. doi: 10.2147/CCIDE.S542349. eCollection 2025.
2
Primary vs. second primary cT1-T2 oral squamous cell carcinoma: comparing the outcomes.原发性与继发性cT1-T2期口腔鳞状细胞癌:疗效比较
Front Surg. 2025 Jul 24;12:1610776. doi: 10.3389/fsurg.2025.1610776. eCollection 2025.
3
Uncovering biomarkers and pathways in oral squamous cell carcinoma through integrated lncRNA-mRNA regulatory network analysis.

本文引用的文献

1
Malignant neoplasms of the oral cavity and oropharynx treated in Brazil: what do hospital cancer records reveal?巴西口腔和口咽恶性肿瘤的治疗情况:医院癌症记录揭示了什么?
Braz J Otorhinolaryngol. 2022 Mar-Apr;88(2):168-173. doi: 10.1016/j.bjorl.2020.05.019. Epub 2020 Jun 24.
2
Survival analysis of oropharyngeal squamous cell carcinoma patients linked to histopathology, disease stage, tumor stage, risk factors, and received therapy.口咽鳞状细胞癌患者的生存分析,与组织病理学、疾病分期、肿瘤分期、危险因素及接受的治疗相关。
Exp Oncol. 2020 Mar;42(1):51-59. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-1.14147.
3
通过整合lncRNA-mRNA调控网络分析揭示口腔鳞状细胞癌中的生物标志物和信号通路
Discov Oncol. 2025 Aug 4;16(1):1462. doi: 10.1007/s12672-025-02922-4.
4
TrkA Expression as a Novel Prognostic Biomarker in Oral Squamous Cell Carcinoma.TrkA表达作为口腔鳞状细胞癌一种新的预后生物标志物
Int J Mol Sci. 2025 Jul 16;26(14):6847. doi: 10.3390/ijms26146847.
5
Association of ALDH3A1 expression with tumor differentiation, pathological stage, and nodal status in oral squamous cell carcinoma.醛脱氢酶3A1(ALDH3A1)表达与口腔鳞状细胞癌肿瘤分化、病理分期及淋巴结状态的相关性
J Taibah Univ Med Sci. 2025 Jun 24;20(3):396-404. doi: 10.1016/j.jtumed.2025.06.007. eCollection 2025 Jun.
6
Nomograms for predicting prognosis in postoperative lip squamous cell carcinoma patients.预测唇部鳞状细胞癌术后患者预后的列线图
Discov Oncol. 2025 Jun 4;16(1):1001. doi: 10.1007/s12672-025-02869-6.
7
Algorithm-based analysis of lymph node dissection strategies and survival outcomes in primary oral squamous cell carcinoma.基于算法的原发性口腔鳞状细胞癌淋巴结清扫策略与生存结果分析
Front Oncol. 2025 Apr 16;15:1483921. doi: 10.3389/fonc.2025.1483921. eCollection 2025.
8
A bibliometric analysis of programmed cell death in oral cancer literature: research patterns and emerging trends (2000-2024).口腔癌文献中程序性细胞死亡的文献计量分析:研究模式与新趋势(2000 - 2024年)
Discov Oncol. 2025 Apr 22;16(1):585. doi: 10.1007/s12672-025-02410-9.
9
Secondary Primary Carcinoma Arising on the Flap Skin in the Oral Cavity-Case Series.口腔皮瓣上发生的继发性原发性癌——病例系列
Diseases. 2024 Dec 12;12(12):324. doi: 10.3390/diseases12120324.
10
The epidemiological and histopathological factors for delayed local recurrence in oral squamous cell carcinoma.口腔鳞状细胞癌局部延迟复发的流行病学和组织病理学因素。
Maxillofac Plast Reconstr Surg. 2024 Nov 12;46(1):38. doi: 10.1186/s40902-024-00443-8.
Head and neck squamous cell carcinoma in young patients: a 26-year clinicopathologic retrospective study in a Brazilian specialized center.
年轻患者头颈部鳞状细胞癌:巴西一家专门中心的 26 年临床病理回顾性研究。
Med Oral Patol Oral Cir Bucal. 2020 May 1;25(3):e416-e424. doi: 10.4317/medoral.23461.
4
Global trends in oral and pharyngeal cancer incidence and mortality.全球口腔和咽癌发病率和死亡率趋势。
Int J Cancer. 2020 Aug 15;147(4):1040-1049. doi: 10.1002/ijc.32871. Epub 2020 Jan 30.
5
Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study?头颈部癌症的合并症:在基于人群的研究中,它与治疗延误、治疗后死亡率和生存有关吗?
Oral Oncol. 2020 Mar;102:104561. doi: 10.1016/j.oraloncology.2019.104561. Epub 2020 Jan 7.
6
Impact of comorbidities on perioperative outcomes for carcinoma of oral cavity.合并症对口腔癌围手术期结局的影响。
Ann R Coll Surg Engl. 2020 Mar;102(3):232-235. doi: 10.1308/rcsann.2019.0155. Epub 2019 Dec 16.
7
Mortality from oral and oropharyngeal cancer in Brazil: impact of the National Oral Health Policy.巴西口腔和口咽癌死亡率:国家口腔健康政策的影响
Cad Saude Publica. 2019 Nov 28;35(12):e00014319. doi: 10.1590/0102-311X00014319. eCollection 2019.
8
Survival of Oral Cancer Patients in Different Ethnicities.不同种族口腔癌患者的生存率。
Cancer Invest. 2019;37(7):275-287. doi: 10.1080/07357907.2019.1635614. Epub 2019 Jul 15.
9
Survival and associated factors among patients with oral squamous cell carcinoma (OSCC) in Mulago hospital, Kampala, Uganda.乌干达坎帕拉穆拉戈医院口腔鳞状细胞癌(OSCC)患者的生存情况及相关因素
Cancers Head Neck. 2018 Oct 26;3:9. doi: 10.1186/s41199-018-0036-6. eCollection 2018.
10
Survival Rates According to Tumour Location in Patients With Surgically Treated Oral and Oropharyngeal Squamous Cell Carcinoma.接受手术治疗的口腔和口咽鳞状细胞癌患者按肿瘤部位划分的生存率
Anticancer Res. 2019 May;39(5):2527-2533. doi: 10.21873/anticanres.13374.